retatrutide mechanism of action retatrutide clinical trials 2024 2025 Triple Agonism Based Therapies for Obesity | Current Cardiovascular Risk Reports Exploring Retatrutide Benefits for Weight

A phase III trial (NCT01909453) compares the effectiveness and safety of LGX818 with MEK162 to vemurafenib and LGX818 monotherapy in patients with locally progressed, unresectable, or metastatic melanoma with the BRAF V600 mutation in two parts

Postmortem human study demonstrated MPs/NPs were 730 times higher in frontal cortex than kidney or liver, with 75% of particles identified as PE (Nihart et al., 2025)

| 11.26.25 | 5 min read

S.SamiduraiM.ChangY

A study showed their omega-3 index score went from 3.1 to 4.8 after 4 months of taking 172mg DHA & 82mg of EPA per day

Carnosine (France, 56 days): AGEs (~64% epidermis